AJI9561, a new cytotoxic benzoxazole derivative produced by Streptomyces sp.
Pharmaceutical Research Laboratories, Ajinomoyo Co Inc, Japan.
S
S
Sato
T
T
Kajiura
M
M
Noguchi
K
K
Takehana
T
T
Kobayashi
T
T
Tsuji
D000970:Antineoplastic Agents / Q000737:chemistry* / Q000302:isolation & purification / Q000378:metabolism / Q000494:pharmacology*; D001583:Benzoxazoles / Q000737:chemistry* / Q000378:metabolism / Q000494:pharmacology*; D004354:Drug Screening Assays, Antitumor; D004791:Enzyme Inhibitors / Q000737:chemistry / Q000302:isolation & purification / Q000378:metabolism / Q000494:pharmacology; D005285:Fermentation; D006801:Humans; D020128:Inhibitory Concentration 50; D009682:Magnetic Resonance Spectroscopy; D015394:Molecular Structure; D013302:Streptomyces / Q000145:classification / Q000378:metabolism*; D059005:Topoisomerase II Inhibitors
C423665:AJI 9561; D000970:Antineoplastic Agents; D001583:Benzoxazoles; D004791:Enzyme Inhibitors; D059005:Topoisomerase II Inhibitors